|
|
Volumn 30, Issue 8, 2012, Pages 731-732
|
|
Genentech's Alzheimer's antibody trial to study disease prevention.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID BETA PROTEIN;
CRENEZUMAB;
MONOCLONAL ANTIBODY;
ALZHEIMER DISEASE;
CLINICAL TRIAL (TOPIC);
DRUG INDUSTRY;
HUMAN;
METABOLISM;
METHODOLOGY;
NOTE;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
HUMANS;
|
|
EID: 84873487586
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0812-731 Document Type: Note |
|
Times cited : (36)
|
|
References (0)
|
